Minimally invasive direct coronary artery bypass grafting for third-time coronary artery revascularization

Shigeki Tabata1, Go Watanabe, Kenji Iino

  • 1Department of General and Cardiothoracic Surgery, Kanazawa University School of Medicine, Kanazawa, Japan.

Insights

Minimally invasive direct coronary artery bypass (MIDCAB) offers a viable solution for complex, repeat revascularization. Both patients in this study showed successful outcomes with widely patent new grafts after their third bypass surgery.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery

Background:

  • Coronary artery disease often requires multiple revascularization procedures.
  • Previous bypass grafts can fail, necessitating further intervention.
  • Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) is an option for complex cases.

Observation:

  • Two patients underwent third-time revascularization using the MIDCAB technique.
  • Patient 1: 66-year-old female with occluded radial artery graft, received right gastroepiploic artery MIDCAB for posterolateral branch revascularization.
  • Patient 2: 65-year-old male with occluded vein grafts and stenotic arterial grafts, received bilateral radial artery-Y graft MIDCAB.

Findings:

  • Postoperative angiography confirmed widely patent new grafts in both patients.
  • Successful revascularization was achieved in complex, previously operated coronary arteries.
  • MIDCAB provided a solution for patients with failed prior grafts and complex anatomy.

Implications:

  • MIDCAB can be a successful strategy for third-time coronary revascularization.
  • This technique offers a less invasive approach for complex repeat bypass surgery.
  • The use of gastroepiploic and radial artery grafts shows promise in repeat revascularization scenarios.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...